Securian Asset Management’s Integra LifeSciences IART Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-5,539
Closed -$196K 933
2024
Q1
$196K Sell
5,539
-200
-3% -$8K 0.01% 909
2023
Q4
$250K Sell
5,739
-259
-4% -$10.2K 0.01% 891
2023
Q3
$229K Sell
5,998
-349
-5% -$14.7K 0.01% 894
2023
Q2
$261K Sell
6,347
-186
-3% -$8.95K 0.01% 883
2023
Q1
$375K Sell
6,533
-100
-2% -$5.63K 0.01% 784
2022
Q4
$372K Hold
6,633
0.01% 776
2022
Q3
$281K Buy
6,633
+123
+2% +$6.3K 0.01% 820
2022
Q2
$352K Hold
6,510
0.01% 826
2022
Q1
$418K Hold
6,510
0.01% 824
2021
Q4
$436K Hold
6,510
0.01% 821
2021
Q3
$446K Hold
6,510
0.01% 805
2021
Q2
$444K Sell
6,510
-100
-2% -$7.07K 0.01% 814
2021
Q1
$457K Sell
6,610
-100
-1% -$6.78K 0.01% 804
2020
Q4
$436K Sell
6,710
-164
-2% -$8.82K 0.01% 758
2020
Q3
$325K Sell
6,874
-258
-4% -$12.3K 0.01% 811
2020
Q2
$335K Sell
7,132
-133
-2% -$6.54K 0.01% 800
2020
Q1
$325K Hold
7,265
0.01% 755
2019
Q4
$423K Sell
7,265
-703
-9% -$41.8K 0.01% 818
2019
Q3
$479K Sell
7,968
-552
-6% -$32.9K 0.01% 781
2019
Q2
$476K Sell
8,520
-32
-0.4% -$1.65K 0.01% 809
2019
Q1
$477K Hold
8,552
0.01% 802
2018
Q4
$386K Sell
8,552
-100
-1% -$5.49K 0.01% 827
2018
Q3
$570K Sell
8,652
-115
-1% -$7.15K 0.01% 751
2018
Q2
$565K Buy
+8,767
New +$543K 0.01% 751

Other funds holding IART

Securian Asset Management's IART Position: Q2 2024 in Review

Securian Asset Management sold out of Integra LifeSciences (IART) in Q2 2024, closing a stake of 5,539 shares — an estimated $196K sold.

Securian Asset Management first reported a position in IART in Q2 2018 and held it in 24 quarters. The position peaked at $570K in Q3 2018. 238 funds tracked by Wall St. Rank hold IART as of Q2 2024.

  • Securian Asset Management reported no remaining Integra LifeSciences position as of Q2 2024 after selling out during the quarter.
  • Securian Asset Management sold 5,539 Integra LifeSciences shares in Q2 2024, an estimated $196K.
  • Securian Asset Management first reported a position in Integra LifeSciences in Q2 2018 and held it in 24 quarters.
  • Securian Asset Management's Integra LifeSciences position peaked at $570K in Q3 2018.
  • 238 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2024.

Based on Securian Asset Management's 13F filing for Q2 2024, filed 15 Jul 2024.